ReviewPediatric research2026
Overview of T-cell subsets and related cytokines in Kawasaki disease.
Review in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Metabolic reprogramming rewires aberrant immune responses to drive endothelial dysfunction in Kawasaki disease: a narrative review.Translational pediatrics · 2026Review
- FOS regulation of T-cell activation and the mechanism of inflammatory injury of coronary endothelium in Kawasaki disease.Translational pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kawasaki disease (KD) is an acute febrile inflammatory illness in children characterized by systemic vasculitis; the etiology and pathogenesis have not been fully clarified. In recent years, studies have shown that T cell-mediated immune abnormalities play an important role in the development of KD. This paper reviewed the dynamic changes of T cell subsets (e.g., Th1, Th17, Treg, etc.) and their regulatory mechanisms in KD, focusing on the molecular mechanisms of T cell-mediated cytokine storm, autoimmune response and vascular injury. In addition, this paper summarizes the research progress of T cell-targeted therapy in KD, which provides a new theoretical basis for the optimization of clinical intervention strategies. By systematically combing the roles and mechanisms of T cells in KD, aims to provide reference for further elucidation of its pathogenesis and development of novel therapeutic approaches. IMPACT: T cells exhibit different immune responses in physiological and pathological states. Different T cell subsets are functionally diverse. Different T cell subsets in patients with Kawasaki disease exhibit significant differences in activity that correlate with therapeutic efficacy. Studies of T cell subsets reveal potential immunotherapeutic targets and improve our understanding of Kawasaki disease.
Identifiers
42026214What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.